Delivery Order SPE2DB20D9331-SPE2DB23FL1L0
Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $50K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,978.75 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML and has a completion date of July 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,573.50, is for the delivery of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical distributor based in Park Ridge, Illinois. The $90,538.50 firm fixed-price contract is for the delivery of BEYFORTUS 100 mg/mL syringes. The award has no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued up to $4,999,999 through 2025. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of BEYFORTUS 100 MG/ML SYRINGE/ML. The contract has a ceiling value of $1,629.58 and is set to expire on December 8, 2023. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, valued at $5,432.31, is for the delivery of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has previously held indefinite delivery contracts with DLA to...
- The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The order, valued at $21,729.24, has a completion date of February 2, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and supports...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,295.36 firm fixed-price delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a ceiling value of $5,295.36 and an ultimate completion date of March 11, 2024. This award is part of a larger indefinite delivery vehicle (IDV) contract #SPE2DB24D9134 between DMS Pharmaceutical Group...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of BEYFORTUS 100 MG/ML SYRINGE ML, a pharmaceutical product, with a potential value of $9,053.85. It is a firm fixed-price contract with a completion date of February 2, 2024. DMS Pharmaceutical Group is a pharmaceutical wholesaler that provides a range of prescription and over-the-counter...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $14,486.24 order is for BEYFORTUS 100 MG/ML SYRINGEML with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract with DLA valued up to $4,999,999 through 2025 to provide a broad range of pharmaceutical items to military health facilities....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $126,753.90 firm fixed-price delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds an Indefinite Delivery Vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, with the DLA valued at up to $4,999,999 through...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB23FL1L0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $50,490.00 firm fixed-price contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a period of performance through August 28, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order is not associated with a set-aside program.
Generated 1/9/25, 9:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 8/25/23 |